Miaohan Qiu

524 total citations
41 papers, 168 citations indexed

About

Miaohan Qiu is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Miaohan Qiu has authored 41 papers receiving a total of 168 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Cardiology and Cardiovascular Medicine, 19 papers in Surgery and 8 papers in Internal Medicine. Recurrent topics in Miaohan Qiu's work include Acute Myocardial Infarction Research (27 papers), Antiplatelet Therapy and Cardiovascular Diseases (24 papers) and Coronary Interventions and Diagnostics (15 papers). Miaohan Qiu is often cited by papers focused on Acute Myocardial Infarction Research (27 papers), Antiplatelet Therapy and Cardiovascular Diseases (24 papers) and Coronary Interventions and Diagnostics (15 papers). Miaohan Qiu collaborates with scholars based in China, Australia and United States. Miaohan Qiu's co-authors include Yaling Han, Yi Li, Kai Xu, Jing Li, Xiaozeng Wang, Yi Li, Quanmin Jing, Xiaoyan Wang, Chenghui Yan and Haiwei Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Miaohan Qiu

34 papers receiving 166 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miaohan Qiu China 8 130 74 28 18 17 41 168
Nikolaos Spinthakis United Kingdom 8 153 1.2× 60 0.8× 47 1.7× 16 0.9× 11 0.6× 20 200
Filipe Seixo Portugal 7 117 0.9× 18 0.2× 22 0.8× 12 0.7× 23 1.4× 37 156
María Paz Fuset Spain 7 81 0.6× 46 0.6× 13 0.5× 13 0.7× 13 0.8× 8 137
Anton Sabashnikov United Kingdom 7 68 0.5× 24 0.3× 14 0.5× 14 0.8× 11 0.6× 14 145
Manolis Vavouranakis Greece 9 183 1.4× 94 1.3× 25 0.9× 4 0.2× 16 0.9× 24 229
Stylianos Tzeis Greece 8 147 1.1× 22 0.3× 6 0.2× 18 1.0× 15 0.9× 16 186
Verghese Mathew United States 6 182 1.4× 134 1.8× 31 1.1× 8 0.4× 61 3.6× 7 260
Nicola Ammirabile Italy 8 103 0.8× 105 1.4× 24 0.9× 5 0.3× 8 0.5× 17 204
Elton Dudink Netherlands 10 261 2.0× 22 0.3× 19 0.7× 6 0.3× 11 0.6× 19 287
Kazumiki Nomoto Japan 7 62 0.5× 38 0.5× 22 0.8× 10 0.6× 6 0.4× 15 125

Countries citing papers authored by Miaohan Qiu

Since Specialization
Citations

This map shows the geographic impact of Miaohan Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miaohan Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miaohan Qiu more than expected).

Fields of papers citing papers by Miaohan Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miaohan Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miaohan Qiu. The network helps show where Miaohan Qiu may publish in the future.

Co-authorship network of co-authors of Miaohan Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Miaohan Qiu. A scholar is included among the top collaborators of Miaohan Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miaohan Qiu. Miaohan Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xiaolin, Miaohan Qiu, Ming‐Huei Cheng, et al.. (2025). Kynurenic Acid Is a Predictive Prognostic Metabolic Marker in ST‐Elevation Myocardial Infarction. Cardiovascular Therapeutics. 2025(1). 9123654–9123654.
2.
Liu, Haiwei, Yi Li, Guosheng Fu, et al.. (2025). Sirolimus- vs Paclitaxel-Coated Balloon for the Treatment of Coronary In-Stent Restenosis. JACC: Cardiovascular Interventions. 18(8). 963–971. 4 indexed citations
3.
Li, Yang, Zhenyang Liang, Yi Li, et al.. (2025). Ticagrelor vs. clopidogrel in bivalirudin-treated patients with STEMI undergoing primary PCI: The BRIGHT-4 trial. Cardiovascular revascularization medicine. 83. 10–16.
7.
Qiu, Miaohan, et al.. (2024). Drug-coated balloon angioplasty versus drug-eluting stent implantation in ACS patients with different angiographic patterns of in-stent restenosis. International Journal of Cardiology. 415. 132450–132450. 1 indexed citations
8.
Liao, Jia, Miaohan Qiu, Xiaojian Feng, et al.. (2024). Bivalirudin versus heparin in patients with or without bail-out GPI use: a pre-specified subgroup analysis from the BRIGHT-4 trial. BMC Medicine. 22(1). 410–410. 1 indexed citations
10.
Qiu, Miaohan, et al.. (2024). Triglyceride to high density lipoprotein cholesterol ratio and major adverse cardiovascular events in ACS patients undergoing PCI. Scientific Reports. 14(1). 31752–31752. 1 indexed citations
11.
Qiu, Miaohan, Xiaolin Su, Ying Xu, et al.. (2024). The residual risk of inflammation and remnant cholesterol in acute coronary syndrome patients on statin treatment undergoing percutaneous coronary intervention. Lipids in Health and Disease. 23(1). 172–172. 5 indexed citations
12.
Qiu, Miaohan, et al.. (2023). Effect of dual antiplatelet therapy prolongation in acute coronary syndrome patients with both high ischemic and bleeding risk: insight from the OPT-CAD study. Frontiers in Cardiovascular Medicine. 10. 1201091–1201091. 2 indexed citations
16.
Zhang, Xiaolin, Yi Cai, Xu Su, et al.. (2022). Untargeted metabolomics identified kynurenine as a predictive prognostic biomarker in acute myocardial infarction. Frontiers in Immunology. 13. 950441–950441. 8 indexed citations
17.
Li, Yi, Chenghui Yan, Xiaolin Zhang, et al.. (2022). Clonal hematopoiesis of indeterminate potential in patients with acute coronary syndrome undergoing percutaneous coronary intervention in the absence of traditional risk factors. Clinical Research in Cardiology. 112(4). 506–517. 10 indexed citations
18.
Qiu, Miaohan, et al.. (2021). Comparison of the efficacy and safety of ticagrelor and clopidogrel in patients with acute coronary syndrome after risk stratification. Catheterization and Cardiovascular Interventions. 97(S2). 1032–1039. 3 indexed citations
19.
Qiu, Miaohan, et al.. (2020). Dual Antiplatelet Therapy Duration in Medically Managed Acute Coronary Syndrome Patients: Sub-Analysis of the OPT-CAD Study. Advances in Therapy. 37(7). 3150–3161. 1 indexed citations
20.
Zhao, Ren, Kai Xu, Yi Li, Miaohan Qiu, & Yaling Han. (2018). Percutaneous coronary intervention in patients with acute coronary syndrome in Chinese Military Hospitals, 2011–2014: a retrospective observational study of a national registry. BMJ Open. 8(10). e023133–e023133. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026